A medicine designed to improve levels of “good” cholesterol may also help control blood sugar in people with diabetes who are taking cholesterol-lowering drugs, according to a recently published study.
Researchers made the finding while analysing data from a clinical trial on the drug torcetrapib. Torcetrapib is a cholesterol ester transfer protein (CETP) inhibitor, a type of drug that increases levels of high-density lipoproteins (HDLs, or ‘good’ cholesterol).
The study found that 6661 people with type 2 diabetes - also known as “adult-onset” diabetes - showed improved blood sugar control when taking torcetrapib along with a statin medication that reduces low-density lipoproteins (LDLs or ‘bad’ cholesterol). Subjects who took a statin and a placebo did not see such improvements.
Read more at University of Sydney